Fibrinogen Early In Severe Trauma studY Update
Trauma is the leading cause of death worldwide in individual's aged 18-39 with data from the WHO suggesting that worldwide almost 6 million deaths every year are directly attributable to trauma. Despite advances in trauma management, a significant proportion of these deaths are still due to haemorrhage. Death can occur early as a result of uncontrollable haemorrhage; in patients where surgical haemorrhage control is achieved subsequent morbidity and mortality can be attributed to effects of massive haemorrhage and large volume blood product transfusion. This session will provide an update for the Feisty Study - An Australian multi-centre randomised, controlled trial studying the effects of rapid fibrinogen replacement in severely bleeding trauma patients.
|Presenter:||Dr James Winearls, Consultant Intensivist, Gold Coast University Hospital, (Chief Investigator).|
- Improve awareness of the FEISTY study
- Describe the possible future implications